Neurodegeneration and neuroprotection: Current state of research - Introduction to the topic;Neurodegeneration und neuroprotektion: Aktueller forschungsstand

Ophthalmologe

Volumn 101, Issue 11, 2004, Pages 1059-1061

  Schmidt, K G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; AMPA RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER;

ANTIOXIDANT ACTIVITY; APOPTOSIS; DIABETIC RETINOPATHY; HUMAN; HYPOXIA; MEMBRANE POTENTIAL; MICROCIRCULATION; NERVE DEGENERATION; NEUROPROTECTION; SHORT SURVEY; ARTICLE; GLAUCOMA; OPTIC NERVE DISEASE; RETINA DEGENERATION;

GLAUCOMA; HUMANS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RETINAL DEGENERATION;

EID: 12444288004     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-004-1104-3     Document Type: Short Survey

References (60)

1. Akaike A, Tamura Y, Yokota T, Shimohama S, Kimura J (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644:181-187
2. Andres N, Malpesa Y, Rodriguez MJ, Mahy N (2003) Low sensitivity of retina to AMPA-induced calcification. J Neurosci Res 72:543-548
3. Araki CM, Pires RS, Britto LP, Lindstrom JM, Karten HJ, Hainassaki Britto DE (1997) Differential colocalization of nicotinic acetylcholine receptor subunits with calcium-binding proteins in retinal ganglion cells. Brain Res 774:250-255
4. Baldridge WH (1996) Optical recordings of the effects of cholinergic ligands on neurons in the ganglion cell layer of mammalian retina. J Neurosci 16:5060-5072
5. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791
6. Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283-290
7. Better B, Mulle C (1995) Review: neurotransmitter receptors. IL AMPA and kainate receptors. Neuropharmacology 34:123-139
8. Bonne C, Müller A, Villain M (1998) Free radicals in retinal ischemia. Gen Pharmacol 30:275-280
9. Brandstatter JH, Hartveit E, Sassoe Pognetto M, Wassle H (1994) Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci 6:1100-1112
10. Browniee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
11. Brunken WJ, Jin XT, Pis-Lopez AM (1993) The properties of the serotonergic system in the retina. In: Osborne NN, Chader GJ (eds) Progress in Retinal Research. Pergamon, Oxford, S 75-100
12. Cerami A, Vlassara H, Browniee M (1988) Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11 (Suppl):73-79
13. Chen HS, Lipton SA (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol Lond 499:27-46
14. Chidlow G, Schmidt KG, Wood JPM, Osborne NN (2002) Lipoic acid protects the retina against ischaemia/reperfusion. Neuropharmacology 43:1015-1025
15. Douglas GR (1998) Pathogenetic mechanisms of glaucoma not related to intraocular pressure. Curr Opin Ophthalmol 9:34-38
16. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299-305
17. Durany N, Munch G, Michel T, Riederer P (1999) Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci 249:68-73
18. Dykens JA (1997) Mitochondrial free radical production and oxidative pathophysiology: implications for neurodegenerative disease. In: Beal MF, Howell N (eds) Mitochondria and free radicals in neurodegenerative diseases. Wiley-Liss, New York, S 29-55
19. Galzi JL, Changeux JP (1995) Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 34:563-582
20. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61:33-44
21. Hammes HP, Browniee M, Lin J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603-607
22. Hartveit E, Brandstatter JH, Sassoe Pognetto M, Laurie DJ, Seeburg PH, Wassle H (1994) Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina. J Comp Neurol 348:570-582
23. Lieth E, Gardner TW, Barber AJ, Antonetti DA (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3-8
24. Lipton SA (1988) Spontaneous release of acetylcholine affects the physiological nicotinic responses of rat retinal ganglion cells in culture. J Neurosci 8:3857-3868
25. Ludwig B, Bender E, Arnold S, Huttemann M, Lee I, Kadenbach B (2001) Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chembiochem 2:392-403
26. Lukasiewicz PD, Shields CR (1998) Different combinations of GABAA and GABAc receptors confer distinct temporal properties to retinal synaptic responses. J Neurophysiol 79:3157-3167
27. Lyden PD (1997) GABA and neuroprotection. Int Rev Neurobiol 40:47-70
28. Marin P, Maus M, Desagher S, Glowinski J, Premont J (1994) Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity [see comments]. Neuroreport 5:1977-1980
29. Massey SC, Linn DM, Kittila CA, Mirza W (1997) Contributions of GABAA receptors and GABAc receptors to acetylcholine release and directional selectivity in the rabbit retina. Vis Neurosci 14:939-948
30. Mittag TW, Serie J, Schumer R et al. (1994) Studies of the ocular pulse in primates. Surv Ophthalmol 38 (Suppl):183-190
31. Monnier L (1989) Proceedings of the spring meeting of the French Language Association for the study of diabetes and metabolie diseases. Montpellier, 20-22 April 1989. Rev Prat 39:2622-2624
32. Mori H, Mishina M (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237
33. Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, Buse MG, Gardner TW (2001) Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem 276:43748-43755
34. Nguyen Legros J, Simon A, Caille I, Bloch B (1997) Immunocytochemical localization of dopamine D1 receptors in the retina of mammals. Vis Neurosci 14:545-551
35. Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E, Li QQ (2004) Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med 13:87-92
36. Ogurusu T, Eguchi G, Shingai R (1997) Localization of gamma-aminobutyric acid (GABA) receptor rho 3 subunit in rat retina. Neuroreport 8:925-927
37. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JPM, Nash MS (1999) Neuroprotection in relation to retinal ischaemia and relevance to glaucoma. Surv Opthalmol 43:102-128
38. Osborne NN, Chidlow G, Wood JPM, Schmidt KG, Casson R, Melena J (2001) Expectations in the treatment of retinal diseases: neuroprotection. Curr Eye Res 22:321-322
39. Ozaki H, Yu AY, Della N et al. (1999) Hypoxia inducible factor-lalpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40:182-189
40. Pillunat LE, Lang GK, Harris A (1994) The visual responses to increased ocular blood flow in normal pressure glaucoma. Surv Ophthalmol 38 (Suppl):139-148
41. Quigley HA, Nickells RW, Kerigan LA et al. (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36:774-786
42. Schmidt KG (1999) Antiglaukomatosa und choroidale Perfusion bei primärem und experimentell induziertem Offenwinkelglaukom. In: Schmidt KG, Pillunat LE (Hrsg) Fortbildung Glaukom Bd 1, Perfusion und Pharmakologie. Enke, Stuttgart, S 39-50
43. Schmidt KG, Stegman DY, Serle JB et al. (1991) Ocular pulse amplitude in primary open-angle glaucoma, low tension glaucoma, and in ocular hypertensive patients before and after topical drug treatment. Invest Ophthalmol Vis Sci 32:943
44. Schmidt KG, Mittag TW, Pavlovic S, Hessemer V (1996) Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol 234:527-532
45. Schmidt KG, v. Rückmann A, Geyer O, Mittag TW (1997) Einfluß des Nifedipins auf die okuläre Pulsamplitude bei Normaldruckglaukom. Klin Monatsbl Augenheilkd 210:355-359
46. Schmidt KG, v Rückmann A, Mittag TW, Hessemer V, Pillunat LE (1997) Reduced ocular pulse amplitude in low-tension glaucoma is independent of vasospasm. Eye 11:485-488
47. Schmidt KG, Mittag TW (1998) Ein vasodilatativer Therapieansatz bei Normaldruckglaukom. In: Schmidt KG (Hrsg) Glaukom - Aktuelle Diagnostik und Therapie. Ad manum medici, München, S 47-56
48. Schmidt KG (1999) Einfluß antiglaukomatöser Substanzen auf die okuläre Perfusion. In: Pillunat LE, Böhm AG, Schmidt KG (Hrsg) Fortbildung Glaukom Bd 2, Differentialdiagnose, Therapie, Perspektiven. Enke, Stuttgart, S 79-97
49. Schmidt KG, KlingmüllerV, Gouveia SM, Osborne NN, Pillunat LE (2003) Short posterior ciliary artery, central retinal artery and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients. Am J Ophthalmol 136:1038-1048
50. Shamsul Ola M, Moore P, Maddox D et al. (2002) Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res 107:97-107
51. Shimohama S, Akaike A, Kimura J (1996) Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann N Y Acad Sci 777:356-361
52. Shuaib A, Murabit MA, Kanthan R, Howlett W, Wishart T (1996) The neuroprotective effects of gamma-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations. Neurosci Lett 204:1-4
53. Skundric DS, Lisak RP (2003) Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabetes Res 4:303-312
54. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Viassara H (1997) Advanced glycation end products (AGEs) colocalize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523-531
55. Szabo ME, Droy-Lefaix MT, Doly M (1997) Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. Clin Neurosci 4:240-245
56. Trew DR, Smith SE (1991) Postural studies in pulsatile blood flow: I. Ocular hypertension and normotension. Br J Ophthalmol 75:66-70
57. Trew DR, Smith SE (1991) Postural studies in pulsatile ocular blood flow: II. Chronic open-angle glaucoma. Br J Ophthalmol 75:71-75
58. Van Reyk DM, Gillies MC, Davies MJ (2003) The retina: oxidative stress and diabetes. Redox Rep 4:87-92
59. Veruki ML (1997) Dopaminergic neurons in the rat retina express dopamine D2/3 receptors. Eur J Neurosci 9:1096-1100
60. Wood JPM, Schmidt KG, Melena J, Chidlow G, Allmeier H, Osborne NN (2003) The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 76:505-516